Logo

Join us as the ClinGen Somatic and VICC Virtual Molecular Tumor Board teams up with The American College of Medical Genetics and Genomics for an innovative CME case series. This series is intended as a forum to share multidisciplinary experiences in cancer genetics around the world to better understand cancer variant detection methods, genomic interpretation, and cancer patient management.

Upcoming Events:

February

27

 

Cases in Precision Oncology: Highlights from the 2023 ClinGen Somatic Cancer and VICC Virtual Molecular Tumor Board Case Series

 11:00am -12:00pm ET

 

This CME Case Series reflects the work of molecular tumor boards by featuring an interdisciplinary discussion of cases that are subject to comprehensive molecular characterization using a variety of advanced technologies. The molecular characterization of tumor samples ranges from methods on the genomic level to recent advances in proteomics. The field is advancing rapidly, and more and more approaches will translate from basic research to clinical care. In this session, we will summarize the variety of methods described in previous virtual molecular tumor boards and highlight the most interesting cases from 2023. In addition, we will give an outlook on topics to come in 2024.

April 

23

ClinGen Somatic and VICC VMTB CME Case Presentation: Pediatric Oncology

11:00am -12:00pm ET

 

Dr. Annie Garcia, a pediatric cancer specialist, will discuss a case of molecular tumor profiling to inform the diagnosis and treatment plan for a pediatric cancer patient This case highlights some challenges that are unique to the care of pediatric cancer patients.

 

May

28

ClinGen Somatic and VICC VMTB CME Case Presentation: Adventures in a CHIP Clinic

11:00am - 12:00pm ET

Clonal hematopoesis of indeterminate potential (CHIP) is an entity of somatic mutation related to age as well as an increased risk for development of hematologic neoplasms.  Patients with CHIP can benefit from understanding their risk for developing hematologic neoplasms and gaining access to tools for early detection of cancer and potential lifestyle changes.  Drs. Mrinal Patnaik and Terra Lasho discuss cases highlighting the benefits and challenges of CHIP detection and management.

Free Educational Credits Available.

© 2024 American College of Medical Genetics and Genomics. All rights reserved.

Powered By